Kuno, Y <br/><br/>
PR-000350, a novel hypoxic radiosensitizer, enhances tumor cell killing by promoting apoptosis preferentially in the S-phase fraction.  [electronic resource] 

 -  Apoptosis : an international journal on programmed cell death  Feb 2000 
 - 69-77 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1360-8185 
<br/><br/><label>Standard No.: </label>10.1023/a:1009641827022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaerobiosis<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Bromodeoxyuridine--metabolism<br/>Dose-Response Relationship, Radiation<br/>Humans<br/>Imidazoles--pharmacology<br/>Radiation-Sensitizing Agents--pharmacology<br/>S Phase--drug effects<br/>U937 Cells<br/>X-Ray Therapy--methods